Travel during COVID-19 pandemic in Libya: reasons of travel, disease importation and travel regulations.
Travel during pandemics
disease importation
travel policy
Journal
The Libyan journal of medicine
ISSN: 1819-6357
Titre abrégé: Libyan J Med
Pays: United States
ID NLM: 101299403
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
entrez:
25
10
2021
pubmed:
26
10
2021
medline:
28
10
2021
Statut:
ppublish
Résumé
Restriction of mobility between countries is an important regulatory measure to combat pandemics such as the coronavirus disease 2019 (COVID-19). Currently, PCR testing is required to enter the Libyan borders. However, no post-travel quarantine is employed. In this report, we briefly discuss travel regulations in Libya during the COVID-19 pandemic and disease importation by travelers. The results showed that almost half of the sample travel because of health care and therapy reasons. Tunisia was the most visited destination mainly for trading and business and receiving healthcare. Importantly, 13% of asymptomatic travelers were SARS-CoV-2 positive. Issues regarding repeated testing among very frequent travelers and variant importation needs to be addressed in a more efficient manner.
Identifiants
pubmed: 34694964
doi: 10.1080/19932820.2021.1994740
pmc: PMC8547827
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1994740Références
Libyan J Med. 2007 Sep 01;2(3):109-10
pubmed: 21503204
BMJ. 2020 Mar 12;368:m1036
pubmed: 32165426
N Engl J Med. 2020 Mar 26;382(13):1268-1269
pubmed: 32109011
J Infect Dis. 2021 May 28;223(10):1666-1670
pubmed: 33580259
Lancet Infect Dis. 2020 Sep;20(9):993
pubmed: 32860768
Nature. 2021 May;593(7857):136-141
pubmed: 33706364
Lancet Infect Dis. 2021 Jul;21(7):929-938
pubmed: 33765417